An experimental Alzheimer’s drug developed by Biogen showed encouraging early results in slowing the disease by targeting the brain protein tau, offering a different approach from current treatments. Researchers said the findings are promising, but larger clinical trials are needed to confirm the drug’s effectiveness.
Britain tightened its rules on overseas political donations on Monday, as part of efforts to stop foreign money from influencing elections, amid concerns swirling around […]
Britain on Tuesday summoned Iran’s Chargé d’Affaires, Tehran’s most senior diplomat in London, after two Romanian nationals were given lengthy jail sentences over the stabbing […]
India has opposed the proposed 12.5% tariff under the US Trade Representative’s (USTR) Section 301 investigation into alleged forced labour, with industry sources arguing that […]